A Cohort Study on Traditional Chinese Medicine Syndrome Differentiation-based Treatment for Post-COVID-19 Syndrome
Due to the lack of specific Western medicine therapies for post-coronavirus disease 2019 (COVID-19) syndrome in clinical practice, this study aimed to investigate the efficacy of traditional Chinese medicine (TCM) for post-COVID-19 syndrome using a cohort study design and to explore its clinical value in alleviating patients’ symptoms and improving clinical outcomes.
Authors
- Yineng Tan (ORCID: https://orcid.org/0009-0007-5024-6681)
- Rongyuan Yang (ORCID: https://orcid.org/0000-0002-8792-8017)
- Qing Liu (ORCID: https://orcid.org/0000-0002-2199-2999)
- Jinying Qin
- Xiaotu Xi
- Qingyan Liu
- Manning Jian
- Yanfeng Guo
- Danwen Zheng
- Qiuying Deng
Publication Details
- Journal
- Future Integrative Medicine
- Published
- 2026-06-16
- DOI
- https://doi.org/10.14218/fim.2026.00001
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Science and Technology Planning Project of Guangdong Province